Key facts
- This page summarizes Power Dana J. Moss's Form 4 filing for NAVIDEA BIOPHARMACEUTICALS, INC..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Nov 2023, 18:43.
Power Dana J. Moss - 16 Nov 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 16 Nov 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Nov 2023, 18:43:46 UTC
- Prior SEC filing
- 17 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- Gioia Gentile on behalf of Dana J. Moss, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Power Dana J. Moss filed Form 4 for NAVIDEA BIOPHARMACEUTICALS, INC. on 20 Nov 2023.
Change
- Previous filing in this sequence was filed on 17 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NAVB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +200,000
- Change %
- +80%
- Price
- $0.000000
- Shares after
- 450,000
- Date
- 16 Nov 2023
- Ownership
- Direct
- Footnotes
- F1
NAVB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +416,667
- Change %
- +93%
- Price
- $0.000000
- Shares after
- 866,667
- Date
- 16 Nov 2023
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Shares vest on the one-year anniversary of the Grant Date, subject to the Reporting Person's continuous service to the Company.
Footnote F2
Shares vest in three equal tranches, with the first tranche vesting on July 11, 2024 (the "Initial Vesting Date"), with the remaining tranches vesting ratably annually from the Initial Vesting Date over the following two years, subject to the Reporting Person's continuous service to the Company.